Sands Capital Life Sciences Pulse Fund II, L.P.

3.1

3.1

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Inhibikase Therapeutics Inc (IKT)

Transaction date 21 Nov 2025

Purchase

Price

24.74

Quantity 28,138 -40.4%

Value US$1,190,494

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-11-24	2025-11-21	Inhibikase Therapeutics Inc (IKT)	B Purchase	28,138 -40.4% 24.74 US$1,190,494	28,138 -40.4%	24.74	US$1,190,494